The present invention relates to novel monomaleimide-functionalized platinum compounds of formula (I), including in particular novel monomaleimide-functionalized oxaliplatin and carboplatin derivatives, as well as their use as medicaments, particularly for the treatment or prevention of cancer. ##STR00001##

A platinum(IV) complex has the structure of Formula I.

##STR00001##

where X, X′, Y, Y′, and Z are each independently an electron donor ligand, R.sub.1˜R.sub.5 are each independently a functional group, L is the linker unit, and n is selected from the group of 0, a positive charge, and a negative charge. Various methods contain steps for manufacturing the platinum(IV) complex, for treating cancer, a tumor, or an infection in a subject with the platinum(IV) complex. A pharmaceutical composition contains the platinum(IV) complex.

A light-emitting device with high resistance to heat in a fabrication process is provided. The light-emitting device includes an EL layer between an anode and a cathode. The EL layer includes at least a light-emitting layer and an electron-transport layer that includes a first electron-transport layer in contact with the light-emitting layer and a second electron-transport layer in contact with the first electron-transport layer. The first electron-transport layer includes a first heteroaromatic compound including at least one heteroaromatic ring. The second electron-transport layer includes a second heteroaromatic compound that includes at least one heteroaromatic ring and is different from the first heteroaromatic compound. The first heteroaromatic compound has a difference of 20° C. or less between the crystallization temperature (Tpc) of a powder state and the crystallization temperature (Ttc) of a thin film state. The second heteroaromatic compound has a difference of 100° C. or less between Tpc and Ttc.

The invention relates to a method for producing aqueous preparations of complexes of platinum group metals (PGM) Pt, Pd, Rh and Ir having the general formula [M.sup.A/M.sup.B/M.sup.C (L).sub.a (H.sub.2O).sub.b (O.sup.2−).sub.c(OH.sup.−).sub.d](OH—).sub.e(H.sup.+).sub.f, wherein M.sup.A=Pt.sup.II or Pd.sup.II, M.sup.B=Pt.sup.IV, M.sup.C=Rh or Ir, L is a neutral monodentate or bidentate donor ligand, and a is an integer between 1 and 4 (or 2) and/or between 1 and 6 (or 3), b is an integer between 0 and 3 (or 5), c is an integer between 0 and 3 (or 4), d is an integer between 0 and 3 (or 5), e is an integer between 0 and 2 (or 3 or 4) and f is an integer between 0 and 4 (or 5). In the method according to the invention, the hydroxo complexes H.sub.2P.sub.d(OH).sub.4 (in the case of M.sup.A=Pd.sup.II), H.sub.2Pt(OH).sub.6 (in the case of M.sup.A=Pt.sup.II and M.sup.B=Pt.sup.IV) or H.sub.3M.sup.C(OH).sub.6 (for M.sup.C=Rh.sup.III Ir.sup.III) are converted in the presence of the donor ligands, wherein at least one hydroxo group of the hydro complex is exchanged. Preferably, the reaction occurs at temperatures in the range of 40 to 110° C. with a reaction time of between 2 and 24 hours, wherein, where MA=PtII, the conversion additionally occurs in the presence of a reduction agent. The method optionally further comprises an exchange of OH anions bound outside of the complex sphere with other anions (e.g. hydrogen carbonate or carbonate anions). The aqueous preparations contain PGM complexes such as [Pt(en).sub.2](OH).sub.2, [Pt(EA).sub.4](OH).sub.2 or [Rh(NH.sub.3).sub.6](OH).sub.3 and are used to produce electroplating baths, heterogeneous catalysts or metal powders, for example.

This invention discloses oligosilane compounds. These compounds can be used in OLEDs.

Platinum complexes having benzyl-based diphosphine ligands for the catalysis of the alkoxycarbonylation of ethylenically unsaturated compounds.

To provide a novel photoelectric conversion device that is highly convenient, useful, or reliable. The photoelectric conversion device includes a first electrode, a second electrode, and a first unit. The first unit is located between the first electrode and the second electrode. The first unit contains a first electron-donating material and a first electron-accepting material. The first electron-donating material is a condensed aromatic compound, and the first electron-accepting material has a perylene skeleton and two or more alkyl groups. The alkyl groups each independently have 1 to 13 carbon atoms.

The present invention relates to payloads containing functionalized platinum-(benz)acridine hybrid agents as cytotoxic warheads and a method of synthesizing the payloads. The payload can be regioselectively conjugated to a biologically active moiety in order to facilitate the delivery and/or enhance the activity of the platinum compound.

Disclosed are a light-emitting device and a method of manufacturing the same. The light-emitting device includes: a first electrode; a second electrode facing the first electrode; an emission layer between the first electrode and the second electrode and including a quantum dot including a first ligand bonded to a surface thereof; and a charge transport layer including an inorganic nanoparticle including a second ligand bonded to a surface thereof, wherein an interface between the emission layer and the charge transport layer includes a cross-link in which the first ligand on the surface of the quantum dot and the second ligand on the surface of the inorganic nanoparticle are linked by a cross-linking agent.

The present invention includes novel platinum complexes with tridentate ligands forming dimeric structures that are calculated to have blue emission. The ligand backbone and pendant donor rings can be altered to give different emission maxima. The present invention also includes various pendant donor rings and multiple different ligand backbones. Such complexes are suitable for use as an emitter in organic light emitting devices.